Insights on the Canada Dry Powdered Inhaler Market to 2019 | Industry Statistics, Emerging Demands, Forecast to 2025

Canada dry powdered inhaler market is anticipated to grow at a significant CAGR of around 6.8% during the forecast period. The major factors that are contributing significantly to the market growth include growing geriatric population susceptible to respiratory diseases such as asthma and COPD, and high healthcare expenditure. Asthma causes around 350 mortalities every year in the country and it is estimated that over 2 million people live in Canada with Asthma every year. Asthma rates have been increased in Canada over the last 20 years. Although, the fatality rate due to asthma has decreased slightly due to the availability of effective medications. COPD is another respiratory disorder that is the fourth most common cause of mortality in the country and particularly affects women.

To Request a Sample of our Report on Canada Dry Powdered Inhaler Market: https://www.omrglobal.com/request-sample/canada-dry-powdered-inhaler-market

Canada dry powdered inhaler market is segmented based on type, application, and end-user. Based on the type, preventive, reliever, and long-acting bronchodilators inhaler are analyzed. The preventive dry powdered inhaler segment led the global dry powdered inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults. These inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

(Get 15% Discount on Buying this Report)

A full Report of Canada Dry Powdered Inhaler Market is Available at: https://www.omrglobal.com/industry-reports/canada-dry-powdered-inhaler-market

Canada Dry Powdered Inhaler Market Segmentation

By Type

· Preventive Inhaler

· Reliever Inhaler

· Long Acting Bronchodilators Inhaler

By Application

· Asthma

· Chronic Obstructive Pulmonary Disease (COPD)

By End-User

· Homecare

· Hospitals and Clinics

Company Profiles

· 3M Co.

· Acorda Therapeutics, Inc.

· Adamis Pharmaceuticals Corp.

· Adherium Ltd.

· Aradigm Corp.

· AstraZeneca PLC

· Boehringer Ingelheim International GmbH

· Drive Devilbiss Healthcare LLC

· GlaxoSmithKline PLC

· Koninklijke Philips N.V.

· Manta Devices LLC

· Novartis AG

· Omron Healthcare Inc.

· ResMed Corp.

· Pulmatrix Inc.

· Savara, Inc.

· Sunovion Pharmaceuticals

· Teva Pharmaceuticals Industries Ltd.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.